Results 201 to 210 of about 15,079 (253)

The value of proteinuria for the administration of rituximab in patients with PLA2R-associated membranous nephropathy: a single-centre retrospective analysis. [PDF]

Ann Med
Li X, Zhang Y, Xu C, Ke B.
europepmc   +1 more source

The Role of Meprins on the Brain Extracellular Matrix and Perineuronal Nets

The FASEB Journal, Volume 40, Issue 13, 15 July 2026.
Meprin β overexpression is implicated in Alzheimer's Disease. Recent studies identified brevican as a meprin β substrate, and this study demonstrates that meprin α co‐expression enhances meprin β‐mediated brevican cleavage. Further, neurocan and RPTPζ were identified as novel meprin β substrates in an N‐terminomics analysis of meprin β transgenic mice,
Simon Kreiselmaier, Maximilian Keller, Leonardo Nardi, Constantin Mueller, Nele von Wiegen, Kira Bickenbach, Lea Gröbner, Mohammad Abukhalaf, Andreas Tholey, Margareta M. Mueller, Hagen Körschgen, Michael J. Schmeisser, Christoph Becker‐Pauly, Claus U. Pietrzik   +13 more
wiley   +1 more source

Comparison of the efficacy of low, moderate and standard doses of rituximab in the treatment of membranous nephropathy. [PDF]

Front Med (Lausanne)
Guo M, Wan W, Li J, Wu S, Ruan Z, Wang R, Zhang Z, Geng X, Hu X, Ren H.   +9 more
europepmc   +1 more source

Functional characterization of podocyte-expressed THSD7A in experimental membranous nephropathy. [PDF]

JCI Insight
Huang M, Lassé M, Dehde S, Hengel FE, Demir F, Billing AM, Song N, Seifert L, Kretz O, Grahammer F, Panzer U, Brähler S, Huber TB, Zahner G, Rinschen MM, Tomas NM.   +15 more
europepmc   +1 more source

Povetacicept for IgA Nephropathy and Primary Membranous Nephropathy. [PDF]

Kidney Int Rep
Madan A, Yalavarthy R, Kim DK, Moon JY, Park I, Mandayam S, Cortazar F, Kim SG, Enstrom A, Thomas H, Li J, Peng SL, Chen YC, Sanders J, Egbuna O, Tumlin J, AIS-D03 RUBY-3 Study Group.   +16 more
europepmc   +1 more source

Durvalumab-associated membranous nephropathy: a case report and brief literature review. [PDF]

CEN Case Rep
Mizoguchi R, Tashiro T, Sakakima M.
europepmc   +1 more source

Obinutuzumab Versus Rituximab for the Treatment of Primary Membranous Nephropathy: A Systematic Review and Meta-Analysis. [PDF]

Life (Basel)
Lurie A, Daneii P, Khan S, Khan Z, Mansuri H, Bizanti A.   +5 more
europepmc   +1 more source

Circulating Testican-2 and MGT5A are Markers of Membranous Nephropathy. [PDF]

Kidney Int Rep
Kim T, Ju W, Surapaneni A, Li Y, Wen D, Trivin-Avillach C, Rosales IA, Beck LH, Nair V, Fermin D, Zee J, Schmidt IM, Srivastava A, Palsson R, Stillman IE, Kretzler M, NEPTUNE Investigators, Coresh J, Waikar SS, Grams ME, Rhee EP.   +20 more
europepmc   +1 more source

Thromboembolism in the left main coronary artery of a patient with membranous nephropathy: a case report. [PDF]

Front Cardiovasc Med
Wang B, Lu M, Zhang H, Huang C, Zhang W.
europepmc   +1 more source